- PodcastEpisode 69Duration 33:12
Howie and Harlan are joined by health economist Anna Kaltenboeck, a graduate of Yale SOM’s EMBA program who served as senior health advisor to the Senate Finance Committee during the development of the drug pricing reforms in the Inflation Reduction Act. Harlan reports on recent research on the timing of exercise; Howie reflects on the limitations of a blue-ribbon panel’s recommendations on healthcare spending.
- PodcastEpisode 68Duration 33:18
Howie and Harlan are joined by Tara Lagu, a hospitalist, pharmacist, and researcher at Northwestern University, to discuss the startling bias faced by people with disabilities seeking care. Harlan reports on a study of attitudes toward genetic editing of embryos; Howie explains the debate over the looming shortfall in Medicare funding.
- PodcastEpisode 67Duration 36:31
Howie and Harlan are joined by Jeffrey Sonnenfeld, an expert on leadership at the Yale School of Management, to discuss his decades of dialogue with top executives and his insights on healthcare leadership. Harlan reports on his new study exploring the causes of persistent hypertension; Howie reflects on CVS’s acquisition of Oak Street Health and asks who benefits from recent innovations in the healthcare industry.
- PodcastEpisode 66Duration 38:31
Howie and Harlan discuss Howie’s recent bout of COVID-19 and the takeaways from new research on adverse events in hospitals, and they consider claims from Tucker Carlson of Fox News about the pandemic response.
- PodcastEpisode 65Duration 34:58
Howie and Harlan are joined by Leora Horwitz, director of the Rapid Randomized Controlled Trial Lab at NYU Langone Health, to discuss her work using experimentation to improve the delivery of care, and her experience as a clinician and researcher in the chaotic first months of the COVID-19 outbreak in New York City. Harlan reports on his new study examining the impact on patients of early-morning blood draws in hospitals; Howie reflects on new business models for delivering discounted generic drugs.
- PodcastEpisode 64Duration 33:04
Howie and Harlan talk with Gil Addo, CEO and co-founder of RubiconMD, which is aiming to expand access to specialty care by providing virtual consultations to primary care physicians. A new study from Harlan examines a loophole that is allowing unreliable medical devices to enter the market; Howie provides an update on legislature that will soon cause millions to lose Medicaid coverage.
- PodcastEpisode 63Duration 35:33
Howie and Harlan check in on health issues that are in the news—or will be soon. Harlan discusses his work measuring patient outcomes and new avenues of research on long COVID; Howie reports on the perverse effects of private equity investment in specialty healthcare practices and the looming deadline facing state Medicaid programs.
- PodcastEpisode 62Duration 36:10
Harlan answers questions about the cardiac arrest suffered by Buffalo Bills player Damar Hamlin in a nationally televised football game; Howie reports on the rapid spread of the XBB 1.5 variant of COVID-19. And they are joined by F. Perry Wilson, a Yale nephrologist and an expert in the translation of medical research into clinical care, to discuss his new book, How Medicine Works and When It Doesn’t: Learning Who to Trust to Get and Stay Healthy.
- PodcastEpisode 61Duration 36:42
Howie and Harlan are joined by Lisa Sanders, the Yale internist who writes the "Diagnosis" column in the New York Times. Harlan reports on new studies demonstrating the ineffectiveness of ivermectin in treating COVID-19, and the effectiveness of the bivalent booster in improving outcomes. And Howie reacts to headlines about frequent misdiagnoses in emergency departments.
- PodcastEpisode 60Duration 33:16
Harlan reports on a new study suggesting dramatic health benefits from bursts of vigorous activity; Howie explains how genetic science is starting to illuminate a mystery in his own medical history. And they are joined by Yale physician and scientist Jeffrey Gruen to discuss his work identifying the genetic variants associated with dyslexia and designing early interventions for kids with learning disabilities.